Cambridge Antibody Technology's Other Investors

Cambridge Antibody Technology raised a round of funding on , .

Cambridge Antibody Technology is engaged in the development of human monoclonal antibodies as new treatments for disease, having developed a pipeline of human monoclonal antibodies. HUMIRA, an antibod…

Articles about Cambridge Antibody Technology's Other Investors: